RPS6KA3
From Wikipedia, the free encyclopedia
Ribosomal protein S6 kinase, 90kDa, polypeptide 3
|
|||||||||||
Identifiers | |||||||||||
Symbol(s) | RPS6KA3; RSK; CLS; HU-3; ISPK-1; MAPKAPK1B; MRX19; RSK2; S6K-alpha3; p90-RSK2; pp90RSK2 | ||||||||||
External IDs | OMIM: 300075 MGI: 104557 HomoloGene: 37940 | ||||||||||
|
|||||||||||
RNA expression pattern | |||||||||||
Orthologs | |||||||||||
Human | Mouse | ||||||||||
Entrez | 6197 | 110651 | |||||||||
Ensembl | ENSG00000177189 | ENSMUSG00000031309 | |||||||||
Uniprot | P51812 | P18654 | |||||||||
Refseq | NM_004586 (mRNA) NP_004577 (protein) |
NM_148945 (mRNA) NP_683747 (protein) |
|||||||||
Location | Chr X: 20.08 - 20.19 Mb | Chr X: 154.6 - 154.71 Mb | |||||||||
Pubmed search | [1] | [2] |
Ribosomal protein S6 kinase, 90kDa, polypeptide 3, also known as RPS6KA3, is a human gene.[1]
This gene encodes a member of the RSK (ribosomal S6 kinase) family of serine/threonine kinases. This kinase contains 2 non-identical kinase catalytic domains and phosphorylates various substrates, including members of the mitogen-activated kinase (MAPK) signalling pathway. The activity of this protein has been implicated in controlling cell growth and differentiation. Mutations in this gene have been associated with Coffin-Lowry syndrome (CLS).[1]
[edit] References
[edit] Further reading
- Omary MB, Baxter GT, Chou CF, et al. (1992). "PKC epsilon-related kinase associates with and phosphorylates cytokeratin 8 and 18.". J. Cell Biol. 117 (3): 583–93. PMID 1374067.
- Ku NO, Omary MB (1994). "Identification of the major physiologic phosphorylation site of human keratin 18: potential kinases and a role in filament reorganization.". J. Cell Biol. 127 (1): 161–71. PMID 7523419.
- Adams MD, Kerlavage AR, Fleischmann RD, et al. (1995). "Initial assessment of human gene diversity and expression patterns based upon 83 million nucleotides of cDNA sequence.". Nature 377 (6547 Suppl): 3–174. PMID 7566098.
- Zhao Y, Bjørbaek C, Weremowicz S, et al. (1995). "RSK3 encodes a novel pp90rsk isoform with a unique N-terminal sequence: growth factor-stimulated kinase function and nuclear translocation.". Mol. Cell. Biol. 15 (8): 4353–63. PMID 7623830.
- Bjørbaek C, Vik TA, Echwald SM, et al. (1995). "Cloning of a human insulin-stimulated protein kinase (ISPK-1) gene and analysis of coding regions and mRNA levels of the ISPK-1 and the protein phosphatase-1 genes in muscle from NIDDM patients.". Diabetes 44 (1): 90–7. PMID 7813820.
- Donnelly AJ, Choo KH, Kozman HM, et al. (1994). "Regional localisation of a non-specific X-linked mental retardation gene (MRX19) to Xp22.". Am. J. Med. Genet. 51 (4): 581–5. doi: . PMID 7943043.
- Moller DE, Xia CH, Tang W, et al. (1994). "Human rsk isoforms: cloning and characterization of tissue-specific expression.". Am. J. Physiol. 266 (2 Pt 1): C351–9. PMID 8141249.
- Xing J, Ginty DD, Greenberg ME (1996). "Coupling of the RAS-MAPK pathway to gene activation by RSK2, a growth factor-regulated CREB kinase.". Science 273 (5277): 959–63. PMID 8688081.
- Trivier E, De Cesare D, Jacquot S, et al. (1997). "Mutations in the kinase Rsk-2 associated with Coffin-Lowry syndrome.". Nature 384 (6609): 567–70. doi: . PMID 8955270.
- Paudel HK (1997). "Phosphorylation by neuronal cdc2-like protein kinase promotes dimerization of Tau protein in vitro.". J. Biol. Chem. 272 (45): 28328–34. PMID 9353289.
- Joel PB, Smith J, Sturgill TW, et al. (1998). "pp90rsk1 regulates estrogen receptor-mediated transcription through phosphorylation of Ser-167.". Mol. Cell. Biol. 18 (4): 1978–84. PMID 9528769.
- Zheng-Fischhöfer Q, Biernat J, Mandelkow EM, et al. (1998). "Sequential phosphorylation of Tau by glycogen synthase kinase-3beta and protein kinase A at Thr212 and Ser214 generates the Alzheimer-specific epitope of antibody AT100 and requires a paired-helical-filament-like conformation.". Eur. J. Biochem. 252 (3): 542–52. PMID 9546672.
- Deak M, Clifton AD, Lucocq LM, Alessi DR (1998). "Mitogen- and stress-activated protein kinase-1 (MSK1) is directly activated by MAPK and SAPK2/p38, and may mediate activation of CREB.". EMBO J. 17 (15): 4426–41. doi: . PMID 9687510.
- Du K, Montminy M (1999). "CREB is a regulatory target for the protein kinase Akt/PKB.". J. Biol. Chem. 273 (49): 32377–9. PMID 9829964.
- Hanger DP, Betts JC, Loviny TL, et al. (1998). "New phosphorylation sites identified in hyperphosphorylated tau (paired helical filament-tau) from Alzheimer's disease brain using nanoelectrospray mass spectrometry.". J. Neurochem. 71 (6): 2465–76. PMID 9832145.
- Jacquot S, Merienne K, De Cesare D, et al. (1999). "Mutation analysis of the RSK2 gene in Coffin-Lowry patients: extensive allelic heterogeneity and a high rate of de novo mutations.". Am. J. Hum. Genet. 63 (6): 1631–40. PMID 9837815.
- Jacquot S, Merienne K, Pannetier S, et al. (1999). "Germline mosaicism in Coffin-Lowry syndrome.". Eur. J. Hum. Genet. 6 (6): 578–82. doi: . PMID 9887375.
- Smith JA, Poteet-Smith CE, Malarkey K, Sturgill TW (1999). "Identification of an extracellular signal-regulated kinase (ERK) docking site in ribosomal S6 kinase, a sequence critical for activation by ERK in vivo.". J. Biol. Chem. 274 (5): 2893–8. PMID 9915826.
- Abidi F, Jacquot S, Lassiter C, et al. (1999). "Novel mutations in Rsk-2, the gene for Coffin-Lowry syndrome (CLS).". Eur. J. Hum. Genet. 7 (1): 20–6. doi: . PMID 10094187.
- Merienne K, Jacquot S, Pannetier S, et al. (1999). "A missense mutation in RPS6KA3 (RSK2) responsible for non-specific mental retardation.". Nat. Genet. 22 (1): 13–4. doi: . PMID 10319851.